Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Adam J. Bass, Katie S. Nason et al.|Cancer Immunology Research|2015Cited by 139
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (vol 110, pg 662, 2015)Cathy Bennett, Hugh Barr, Pradeep Bhandari et al.|Unknown|2015Cited by 0
Supplementary Figure Legend from Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Adam J. Bass, Xiaoyun Liao et al.|Unknown|2023Cited by 0
Supplementary Methods from Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Adam J. Bass, Katie S. Nason et al.|Unknown|2023Cited by 0
Supplementary Figure S2 from Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal AdenocarcinomaSarah Derks, Adam J. Bass, Katie S. Nason et al.|Unknown|2023Cited by 0